Clinical trial
Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia…
NCT00282581 · Sanofi Pasteur, a Sanofi Company, Industry · Terminated
Key facts
| NCT number | NCT00282581 |
|---|---|
| Title | Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive |
| Official title | A Phase 1, Double-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of MVA3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Vaccinia-Naive Human Immunodeficiency Virus (HIV)-Seropositive Subjects |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Smallpox |
| Intervention type | Biological |
| Interventions | MVA Smallpox Vaccine |
| Enrollment | 2 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2006 |
| Last update posted | Jan 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: